A rare case of MGRS with immunotactoid glomerulopathy responding to bortezomib, dexamethasone, and rituximab

Abstract

Abstract Patients with monoclonal gammopathy of renal significance should be treated with clone‐directed therapy against sources of monoclonal proteins in order to prevent progression to more advanced monoclonal gammopathies and renal failure.

Keywords

• immunotactoid glomerulopathy
• monoclonal gammopathy of renal significance
• nephrotic syndrome
• Waldenstrom's macroglobulinemia